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Abstract A growing body of evidence suggests that mito-
chondrial proton-leak functions as a regulator of reactive
oxygen species production and its modulation may limit
oxidative injury to tissues. The main purpose of this work
was to characterize the proton-leak of brain cortical mito-
chondria from long-term hyperglycemic and insulin-
induced recurrent hypoglycemic rats through the modula-
tion of the uncoupling protein 2 (UCP2) and adenine nucle-
otide translocator (ANT). Streptozotocin-induced diabetic
rats were treated subcutaneously with twice-daily insulin
injections during 2 weeks to induce the hypoglycemic epi-
sodes. No differences in the basal proton-leak, UCP2 and
ANT protein levels were observed between the experimental
groups. Mitochondria from recurrent hypoglycemic rats
presented a decrease in proton-leak in the presence of
GDP, a specific UCP2 inhibitor, while an increase in
proton-leak was observed in the presence of linoleic acid,
a proton-leak activator, this effect being reverted by the
simultaneous addition of GDP. Mitochondria from long-
term hyperglycemic rats showed an enhanced susceptibility
to ANT modulation as demonstrated by the complete inhi-
bition of basal and linoleic acid-induced proton-leak caused
by the ANT specific inhibitor carboxyatractyloside. Our
results show that recurrent-hypoglycemia renders mitochon-
dria more susceptible to UCPs modulation while the proton-
leak of long-term hyperglycemic rats is mainly modulated
by ANT, which suggest that brain cortical mitochondria
have distinct adaptation mechanisms in face of different
metabolic insults.
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Introduction
Coincident with the use of oxygen for aerobic respiration is
the generation of reactive oxygen species (ROS), whose
levels are controlled by endogenous cellular antioxidants
to keep oxidative homeostasis. This is especially relevant
at the mitochondrial level since the respiratory chain is the
major site for ROS production (Naudi et al. 2012). Besides
the antioxidant defense system, the respiratory chain itself
can modulate mitochondrial ROS production through spe-
cific proteins (Leloup et al. 2011). Mitochondrial proton-
leak is a basal or induced permeability of the mitochondrial
inner membrane, resulting in partial dissipation of the trans-
membrane electrochemical gradient (ΔΨm) and uncoupling
of substrate oxidation from ATP synthesis (Brookes 2005).
Since mitochondrial-derived ATP is essential for cellular
functions such uncoupling is often regarded as being detri-
mental. However, a growing body of evidence suggests that
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a low level of proton-leak may have a cytoprotective role
(Mattiasson et al. 2003; Teshima et al. 2003; Hoerter et al.
2004), possibly because mild ΔΨm dissipation diminished
ROS generation, and prevented mitochondrial Ca2+ overload
(Korshunov et al. 1997; Votyakova and Reynolds 2001; Miwa
and Brand 2003). Two groups of mitochondrial carrier pro-
teins contribute significantly to proton leak, uncoupling pro-
teins (UCPs) and the adenine nucleotide translocator (ANT)
(Naudi et al. 2012; Brand and Esteves 2005). The initial
connection between UCPs and ROS came from a study made
by Nègre-Salvayre et al. (Negre-Salvayre et al. 1997) reveal-
ing that the inhibition of UCP1 activated the formation of
ROS in brown fat mitochondria. Subsequent data suggested
that UCP activity may lead to an increase in proton conduc-
tance through the interaction with superoxide anion (O2
−●)
(Echtay et al. 2002) or ROS products (Echtay et al. 2003). The
suggestion that an increased ROS production would lead to
mild-uncoupling that, in turn, would decrease ROS formation,
placed neuronal UCPs as possible important brain damage
modifiers in protecting against oxidative stress (Cardoso et al.
2011). Likewise, mitochondrial proton-leak mediated byANT
has been reported to occur in the presence of lipid peroxida-
tion products leading to a feedback mechanism to protect
against ROS damage (Echtay et al. 2003).
Chronic hyperglycemia is the hallmark of diabetes and
associated complications. High glucose-induced excessive
ROS production has been considered to play an important
role in the onset and progression of diabetes mellitus (DM)
(Rains and Jain 2011). DM is a complex metabolic disorder
characterized by defects in the body’s ability to control
glucose and insulin homeostasis (Rains and Jain 2011).
Accumulating evidence shows that DM is often associated
with complications in the central nervous system which can
lead to cognitive deficits and dementia (Gispen and Biessels
2000). The increased risk for dementia in diabetic patients
may result from direct effects of hyperglycemia, hypogly-
cemia and disrupted insulin signaling in the brain or indirect
ischemic effects of diabetes-promoted cerebrovascular dis-
ease (Craft 2009; Wrighten et al. 2009). Despite the pres-
ence of three UCPs isoforms in the brain, UCP2 has been
the major focus of studies concerning brain damage and
neurodegeneration. It was previously demonstrated that an
increase in brain UCP2 expression was correlated with the
survival of cortical neurons in conditions of oxygen and
glucose deprivation, a situation that was associated with a
decrease in mitochondrial ROS production (Mattiasson et al.
2003). Despite this evidence, the role of UCP2 in diabetes-
induced brain damage remains elusive.
In the present study, our main goal was to characterize the
proton-leak of brain cortical mitochondria, through UCP2 and
ANT modulation, exposed to insulin-induced recurrent hypo-
glycemia and/or long-term hyperglycemia, conditions that
occur in type 1 diabetic patients under insulin therapy.
Materials and methods
Chemicals Streptozotocin was obtained from Sigma
(Portugal). Insulin (Humulin NPH) was obtained from Eli
Lilly and Company (USA). Anti-UCP2 antibody was obtained
from Calbiochem-EMD Chemicals (Gibbstown, USA). All the
other chemicals were of the highest grade of purity commer-
cially available.
Animals treatment Male Wistar rats (2-month-old) were
housed in our animal colony (Laboratory Research Center,
Faculty of Medicine, University of Coimbra) and were
maintained under controlled light (12 hday/night cycle)
and humidity with free access to water and powdered rodent
chow (except in the fasting period). Rats were deprived of
food overnight and were randomly divided in two groups.
One group received an i.p. injection of STZ (50 mg/kg body
weight) freshly dissolved in citrate 100 mM, pH4.5. The
volume administered was always 0.5 ml/200 g animal body
weight. The control group received an i.p. injection with an
equal volume of citrate (vehicle). In the following 24 h,
animals were orally fed with glycosylated serum in order
to avoid hypoglycemia resulting from the massive destruc-
tion of β-cells and release of intracellular insulin associated
with STZ treatment (Moreira et al. 2005). Three days after
STZ administration, the tail vein blood glucose levels were
measured in all animals and those presenting levels above
250 mg/dl were considered diabetic. After 3 months of the
induction of diabetes, the STZ-diabetic rats were randomly
divided in two groups and one group was subjected to
recurrent hypoglycemia achieved by twice-daily injections
of insulin [s.c., dose adjusted to blood glucose levels] during
2 weeks. Animals handling and sacrifice followed the pro-
cedures approved by the Federation of European Laboratory
Animal Science Associations (FELASA).
Determination of blood glucose and glycated hemoglobin
levels Blood glucose concentration was determined from the
tail vein using a commercial glucometer (Glucometer-Elite,
Bayer, Portugal). Hemoglobin A1C (HbA1c) levels were
determined using Systems SYNCHRON CX 4 (Beckman).
This system utilizes two cartridges, Hb and A1c to determine
A1c concentration as a percentage of total Hb. The hemoglo-
bin is measured by a colorimetric method and the A1c con-
centration by a turbidimetric immunoinhibition method.
Preparation of mitochondrial fraction Brain cortical mito-
chondria were isolated from rats according to (Moreira et al.
2001, 2002). In brief, the rat was decapitated, and the cortex
was rapidly removed, washed, minced, and homogenized at
4 °C in 10 ml of isolation medium (225 mM mannitol,
75 mM sucrose, 5 mM HEPES, 1 mM EGTA, 1 mg/ml
BSA, pH7.4) containing 5 mg of bacterial protease type
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VIII (Subtilisin). Single brain homogenates were brought to
20 ml and then centrifuged at 2500 rpm (Sorvall RC-5B
Refrigerated Superspeed Centrifuge) for 5 min. The pellet,
including the fluffy synaptosomal layer, was resuspended in
10 ml of the isolation medium containing 0.02 % digitonin
and centrifuged at 10000 rpm for 10 min. The brown mito-
chondrial pellet without the synaptosomal layer was then
resuspended again in 10 ml of medium and centrifuged at
10000 rpm for 5 min. The pellet was resuspended in 10 ml of
washing medium (225 mM mannitol, 75 mM sucrose, 5 mM
HEPES, pH7.4) and centrifuged at 10000 rpm for 5 min. The
final mitochondrial pellet was resuspended in the washing
medium and mitochondrial protein was determined by the
biuret method calibrated with BSA (Gornall et al. 1949).
Proton-leak measurements In the presence of oligomycin
(ATP synthase inhibitor) the respiration rate is proportional to
the rate of protons leaking through the mitochondrial inner
membrane. The kinetic response of the proton-conductance
pathway to its driving force can therefore be measured as the
relationship between respiration rate and mitochondrial mem-
brane potential, when the potential changes by titration with
electron transport chain inhibitors. Briefly, oxygen consump-
tion and inner membrane potential were simultaneously
recorded using a Clark-type oxygen electrode and a TPP+
electrode, respectively. Cortical brain mitochondria (0.8 mg)
were incubated in 1 ml of reaction medium with 2 μM of
oligomycin, 3μMof rotenone and 80 ng/ml of nigericin (added
to abolish ΔpH so that the total proton-motive force can be
equal to ΔΨm). Experiments started with succinate, a substrate
for complex II. Oxygen consumption and electric potential
were progressively inhibited with sequential additions of
malonate (inhibitor of complex II) up to a total of 2 mM. At
the end of each experiment, 0.2 μM of valinomycin was added
to dissipate the ΔΨm (Cadenas et al. 2000). Titration curves for
stimulation and inhibition of proton-leak were also assessed. To
study UCP2 activation, 5 μM linoleic acid (a known UCP2
activator) (Jaburek et al. 2004) was added before the additions
of malonate. In the experiments involving proton-leak inhibi-
tion, the UCP2 inhibitor guanosine diphosphate (GDP;
750 μM) (Echtay et al. 2003) or the potent and specific ANT
inhibitor carboxyatractyloside (CAtr; 1 μM) were added to the
reaction medium.
Western blotting Mitochondrial fractions were homogenized
in RIPA buffer (50 mM Tris–HCl, 150 mM NaCl, 1 mM
EDTA, 1 % Triton-x100, 1 % deoxycorticosterone, 0.1 %
SDS), protease and phosphatase inhibitors (commercial prote-
ase and phosphatase inhibitors cocktails from Roche), 0.
1 mol/L phenylmethylsulfonyl fluoride, 0.2 mol/L
dithiothreitol, and samples (80 μg of protein per lane) were
run on 10 % SDS-polyacrylamide gels. After electrophoresis,
proteins were transferred to PVDF membranes, and blocked
membranes (1 h in 5%BSA and 0.1%Tween in TBS for 1 h at
room temperature) were incubated overnight at 4 °C with a
rabbit anti-UCP2 antibody (1:1000, Calbiochem), a goat anti-
ANT2/3 (1:100, Santa Cruz) and a rabbit antibody against
cytochrome oxidase subunit IV (COX IV- 1:1000, Cell
Signaling). The proteins were detected separately with the
secondary antibodies, anti-rabbit (1:10000) for UCP2 and
COX-IV detection and anti-goat (1:2500) for ANT2/3. COX
was used as a loading control. The ECF detection system (GE
Healthcare) and Versa Doc imaging system (Bio-Rad) were
used and densities from each band were obtained with Quantity
One Software (Bio-Rad).
Statistical analysis Data were analyzed and results are
presented as mean ± SEM of the indicated number of
experiments. Statistical significance between groups was
defined using the non-parametric Mann–Whitney U-test. A
p-value <0.05 was considered significant.
Results
Characterization of the experimental animals
As expected, long-term hyperglycemic rats presented signif-
icantly higher levels of glycemia and glycated hemoglobin
(HbA1C) and a significant decrease in body weight when
compared with control rats (Table 1). Concerning insulin-
induced recurrent hypoglycemic animals the values
presented in Table 1 reflect the blood glucose levels in the
peak of the hypoglycemic episodes. HbA1C levels in the
recurrent hypoglycemic rats are similar to those of long-
term hyperglycemic rats (Table 1).
The basal proton-leak is similar in mitochondria
from the three groups of experimental animals
An energetically significant leak of protons occurs across
the mitochondrial inner membranes of eukaryotic cells
Table 1 Characterization of the experimental animal models
Control STZ Hypoglycemia
Body weight (g) 444±5.3 300±8.1*** 326±7.8***
Brain weight (g) 2.06±0.03 2.13±0.07 2.21±0.12
Glucose (mg/dl) 123±5.1 467±18.8*** 48±5.6***;+++
HbA1C (%) 3.6±0.03 8.6±0.48
** 7.4±0.13**
Data are the means ± SEM of 6–8 animals from each condition studied.
Statistical significance: *** p<0.001;** p<0.01 when compared with
control rats; +++ p<0.001 when compared with STZ-treated rats.
HbA1C- glycated hemoglobin
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(Stuart et al. 1999). Figure 1a shows that the proton conduc-
tance of mitochondria from the three groups of experimental
animals is similar, although a modest increase in oxygen
consumption in the long-term hyperglycemic mitochondrial
preparation is observed.
Mitochondria from long-term hyperglycemic
and recurrent-hypoglycemic animals do not present
significant alterations in UCP2 and ANT protein levels
The uncoupling or proton-leak can be mediated by UCPs and
by other mitochondrial inner membrane proteins such as the
ANT, which is involved in the modulation of mitochondrial
energy efficiency and responsible for half to two-thirds of
basal proton conductance (Brand et al. 2005). In our work,
no statistically significant alterations were observed in UCP2
protein levels (Fig. 1b), and in the ANT protein levels
(Fig. 1c) of both brain cortical mitochondria from long-
term hyperglycemic and recurrent-hypoglycemic rats.
Mitochondria from long-term hyperglycemic
and recurrent-hypoglycemic rats present a distinct
proton-leak profile
The effect of fatty acids-mediated uncoupling through UCP2
and ANT was evaluated by using linoleic acid. A significant
linoleic acid-induced stimulation of proton-leak was observed
in cortical mitochondria from recurrent hypoglycemic rats, as
demonstrated by the shift of the titration curve to the left
(Fig. 2c). This effect was confirmed by the higher oxygen
consumption needed to achieve the same value of ΔΨm, when
compared with the basal situation (Fig. 2c). In the control
Fig. 1 Effect of STZ-induced long-term hyperglycemia and insulin-in-
duced recurrent hypoglycemia in basal proton-leak (a) and UCP2 (b) and
ANT (c) protein levels of brain cortical mitochondria. (a) Titration curves
to compare basal proton-leak between the experimental conditions. Bar
graphs on the right show the mitochondrial proton-leak at −200 mV. The
value of −200 mV was chosen to perform these comparisons since it is the
value that better represents the median tendency of all curves. Data are the
mean ± SEM of 6–8 animals from each condition studied. Mitochondrial
(b) UCP2 and (c) ANT protein levels. Data are the mean ± SEM of 4–5
animals from each condition studied
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(Fig. 2a) and long-term hyperglycemic (Fig. 2b) mitochondri-
al preparations a slight increase in linoleic acid-induced
proton-leak stimulation was observed (both titration curves
present a modest increase in oxygen consumption for the
same value of ΔΨm).
Additionally, to determine the relative contribution of
either UCPs or ANT to proton-leak, experiments with
GDP or CAtr, inhibitors of UCPs and ANT, respectively,
were performed. Figures 3a and b show that GDP did no
affect proton-leak of control and long-term hyperglyce-
mic mitochondria. However, CAtr induced an inhibitory
effect in proton-leak of control and long-term hypergly-
cemic mitochondria as shown by the shift of the titra-
tion curve to the right, which was accompanied by a
lower oxygen consumption for the same ΔΨm,
suggesting that the proton-leak of mitochondria from
these two experimental groups are modulated by ANT.
Mitochondria from the recurrent hypoglycemic animals
Fig. 2 Effect of linoleic acid on the rate of proton-leak in brain cortical
mitochondria from control (a), STZ-induced long-term hyperglycemic
(b) and insulin-induced recurrent hypoglycemic (c) animals. Bar graphs
on the right show the mitochondrial proton-leak at −200 mV. The value
of −200 mV was chosen to perform these comparisons since it is the value
that better represents the median tendency of all curves. Data are themean ±
SEM of 6–8 animals from each condition studied. *p<0.05 when compared
with hypoglycemic brain cortical mitochondria
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show a high susceptibility to GDP- and CAtr-mediated
proton-leak inhibition that was characterized by a sig-
nificant shift of the titration curve to the right and a low
rate of oxygen consumption (Fig. 3c) suggesting that
both UCPs and ANT modulate proton-leak in hypogly-
cemic animals. This observation was further confirmed
by evaluating the ability of both inhibitors to neutralize
the linoleic acid-induced increase in proton-leak. In fact,
the co-addition of GDP and linoleic acid reduced the
linoleic acid-mediated stimulation of UCPs activity in
mitochondria from insulin-induced recurrent hypoglyce-
mia (Fig. 4c) but not in control (Fig. 4a) and long-term
hyperglycemic (Fig. 4b) rats. Moreover, co-incubation of
CAtr and linoleic acid abolished the stimulatory effect of
linoleic acid in control and long-term hyperglycemic rats
(Figs. 5a and b).
Fig. 3 Effect of GDP and carboxyatractryloside on the rate of proton-leak
in brain cortical mitochondria from control (a), STZ-induced long-term
hyperglycemic (b) and insulin-induced recurrent hypoglycemic (c) animals.
Bar graphs on the right show the mitochondrial proton-leak at −200 mV.
The value of −200 mV was chosen to perform these comparisons since it is
the value that better represents the median tendency of all curves. Data are
the mean ± SEM of 6–8 animals from each condition studied. ***p<0.001
when compared with STZ brain cortical mitochondria; **p<0.01 when
compared with control brain cortical mitochondria; *p<0.05 when com-
pared with hypoglycemic brain cortical mitochondria
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Discussion
To mimic blood glucose levels fluctuations that often occur in
type 1 diabetic patients under intensive insulin therapy (Jacob et
al. 1999; Herzog et al. 2008), we induced recurrent hypoglyce-
mic episodes in long-term hyperglycemic rats. To characterize
brain mitochondrial uncoupling under recurrent hypoglycemia
and/or long-term hyperglycemia, we investigated two
mitochondrial carrier proteins, UCP2 and ANT, which modu-
late mitochondrial proton-leak. Mitochondria from recurrent
hypoglycemic rats exhibited a higher linoleic acid-induced
proton-leak that was inhibited by GDP (Fig. 4c), whereas
mitochondria from long-term hyperglycemic rats were more
susceptible to ANT modulation (Fig. 3b). Mitochondria are
main energy producers and it is believed that an adaption of
mitochondrial efficiency allows the organisms to respond to
Fig. 4 Effect of GDP on the rate of linoleic acid-induced proton-leak
in brain cortical mitochondria from control (a), STZ-induced long-term
hyperglycemic (b) and insulin-induced recurrent hypoglycemic (c)
animals. Bar graphs on the right show the mitochondrial proton-leak
at −200 mV. The value of −200 mV was chosen to perform these
comparisons since it is the value that better represents the median
tendency of all curves. Data are the mean ± SEM of 6–8 animals from
each condition studied. *p<0.05 when compared with hypoglycemic
brain cortical mitochondria
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physiological challenges (Trzcionka et al. 2008). Following this
line of thought we can speculate that brain cortical mitochon-
dria can also develop adaptation mechanisms in face to distinct
metabolic insults.
When ATP synthase (complex V) is not working, either in
the absence of ADP or in the presence of oligomycin (which
blocks the passage of protons through the FO portion of the
ATPase), all protons pumped out of the matrix move back into
the mitochondria through other proton conductance routes.
Flux through this nonproductive proton conductance pathway
has been termed “proton-leak” (Stuart et al. 1999). Therefore,
proton-leak is greatest under nonphosphorylating conditions.
When ADP and Pi are present (state 3 of respiration), ATP
synthase is the favored route of proton reentry to the matrix,
and thus proton-leak is essentially switched off when energy is
needed. An increase in state 4 of respiration alone or a de-
crease in ΔΨm alone is often used as a surrogate for proton-
leak changes (Brookes 2005). Previous data from our labora-
tory shows that mitochondria from rats exposed to metabolic
insults as those described in this study, presented no signifi-
cant differences in the respiratory chain and phosphorylation
system (Cardoso et al. 2012), which suggest that basal proton-
leak is similar in all groups of experimental animals.
Nonetheless, a titration of the respiratory chain activity in
the presence of oligomycin, with simultaneous measurement
of respiration rate and ΔΨm, remains the only effective mea-
sure of proton-leak (Brookes 2005). Accordingly, our titration
experiments showed no statistically significant changes in
proton-leak in mitochondria from the three experimental
groups (Figs. 1a). Furthermore, no significant alterations in
UCP2 protein levels were observed in our experimental
groups (Fig. 1b). Although proton-leak is associated with
UCPs mRNA and protein levels this relation is not straight-
forward. It was previously shown that overnight starvation
increased UCP2/3 mRNA and protein levels, but did not alter
mitochondrial proton-leak (Cadenas et al. 1999). (Herlein et
al. 2009) demonstrated that heart and muscle mitochondria
from diabetic animals were actually more coupled compared
to control animals despite an increase in UCP3 content, thus
demonstrating that expression of UCPs, respiration and
proton-leak are not entirely interrelated. There is also the
assumption that UCP2 and UCP3 do not increase proton
conductance in the absence of activators, as suggested by
studies showing that the knockdown of UCP2 or UCP3 did
not affect basal proton conductance of mouse mitochondria
(Cadenas et al. 2002; Aguirre and Cadenas 2010).
The proton conductance mediated by UCP2 and UCP3 is
activated by fatty-acids and inhibited by purine nucleotides
(Echtay et al. 2001; Chan et al. 2010) and, usually, UCPs
remain inactive in the absence of the activators due to their
inhibition by physiological concentrations of purine nucle-
otides (Brand and Esteves 2005; Jaburek et al. 2004). A
significant linoleic acid-induced proton-leak stimulation
was observed in the recurrent hypoglycemic mitochondria
(Fig. 2c), which was completely inhibited by the co-
incubation with GDP (Fig. 4c). In agreement, GDP strongly
inhibited proton-conductance in mitochondria from the re-
current hypoglycemic rats (Fig. 3c), a situation that was not
observed in mitochondria from control (Fig. 3a) and long-
term hyperglycemic (Fig. 3b) rats. The sensitivity to GDP-
mediated inhibition of proton-leak appears to be indicative
of UCPs involvement in mitochondrial proton conductance
(Chan et al. 2010). A previous study demonstrated that heart
mitochondria from type 2 diabetic mice were GDP sensitive;
however this was not correlated with changes in the expres-
sion levels of UCP3 (Boudina et al. 2007). Similarly, we
observed that recurrent hypoglycemic mitochondria were sus-
ceptible to GDP, although no statistically significant changes
were observed in UCP2 protein levels (Fig. 1b).
The proton-leak mediated by ANT is inhibited by CAtr,
bongkrekic acid, ADP and ATP (Cadenas et al. 2000; Aguirre
and Cadenas 2010). Although no statistically significant
changes occurred in ANT protein levels (Fig. 1c), brain cortical
mitochondria from all experimental groups were susceptible to
CAtr-mediated inhibition of ANT (Figs. 3a, b and c). The
strongest effect of CAtr occurred in long-term hyperglycemic
mitochondria, as shown by the shift of the titration curve to the
right and the significant decrease in oxygen consumption
(Fig. 3b). In agreement, CAtr completely prevented the linoleic
acid-induced uncoupling in mitochondrial preparations from
long-term hyperglycemic rats (Fig. 5b), which may suggest
that ANT-induced proton-leak may play a role under hyper-
glycemic conditions.
The literature shows that uncontrolled blood glucose levels
impact brain structure and function potentiating cognitive im-
pairment, with mitochondrial energy metabolism dysfunction
and oxidative stress being recognized as main players in dia-
betes and related complications (McGowan et al. 2006;
Moreira et al. 2009; Cardoso et al. 2010). The suggestion that
UCPs have a role in diabetes came from studies showing that
muscle mitochondria from type 2 diabetes patients presented
higher state 4 of respiration and proton-leak that were reverted
under a tight glycemic control (Rabol et al. 2009). In endothe-
lial cells, a hyperglycemic insult led to a high increase in the
production of ROS that did not occur when the ΔΨm was
collapsed by overexpressing the enzyme superoxide dismutase
(MnSOD) or UCP1 (Nishikawa et al. 2000), suggesting that
UCP1 have an active role in protecting against hyperglycemia-
induced mitochondrial ROS production. It was also shown that
UCP3 overexpression in dorsal root ganglions (DRG) was able
to prevent the sequence of events associated to glucose-
induced neuronal degeneration (Vincent et al. 2004). In addi-
tion, the hyperglycemic insult led to the loss of UCP3 expres-
sion in DRG neurons suggesting that preventing the loss of
UCP3 may avert glucose-induced neuronal injury (Vincent et
al. 2004). Further, it was also demonstrated that UCP2 was not
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activated directly by O2
−● but rather, the peroxidation of lipids
initiated by O2
−● led to an increase in UCP2-mediated proton
translocation (Murphy et al. 2003). This lipid peroxide-
mediated activation of UCP2 is believed to promote egress of
fatty acid peroxides from the matrix to the intermembrane
space of mitochondria thus making mitochondrial DNA,
aconitase and other mitochondrial matrix-localized compo-
nents less vulnerable to oxidative damage (Jaburek et al.
2004; Goglia and Skulachev 2003). More recently, evidence
suggested that the presence of both free fatty acids and O2
−●
seem to be required for UCP-mediated uncoupling, whereas
O2
−● alone is not able to stimulate proton-leak in skeletal
Fig. 5 Effect of carboxyatractryloside on the rate of linoleic acid-
induced proton-leak in brain cortical mitochondria from control (a),
STZ-induced long-term hyperglycemic (b) and insulin-induced recurrent
hypoglycemic (c) animals. Bar graphs on the right show the mitochon-
drial proton-leak at −200 mV. The value of −200 mV was chosen to
perform these comparisons since it is the value that better represents the
median tendency of all curves. Data are the mean ± SEM of 6–8 animals
from each condition studied. +p<0.05 when compared with control brain
cortical mitochondria plus linoleic acid; ++p<0.01 when compared with
STZ brain cortical mitochondria plus linoleic acid; *p<0.05 when com-
pared with hypoglycemic brain cortical mitochondria
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muscle mitochondria (Lombardi et al. 2008). In agreement,
(Bugger et al. 2008) also reported that fatty acid-induced
mitochondrial uncoupling in type 1 diabetic hearts required a
concomitant increase in the levels of ROS or lipid peroxides.
Fasting, high-fat feeding, and STZ-induced diabetes have been
demonstrated to increase plasma free fatty acids and a positive
correlation between free fatty acids and UCP2 and UCP3
levels in heart (Murray et al. 2005) and liver (Ruiz-Ramirez
et al. 2011) mitochondria was observed. It was also previously
shown that a severe hypoglycemic episode led to increased
levels of free fatty acids in rat cerebral cortex (Agardh and
Siesjo 1981). Besides that, previous findings from our labora-
tory demonstrated that cortical mitochondria from recurrent
hypoglycemic animals exhibited higher levels of lipid peroxi-
dation (malondialdehyde) and oxidative stress markers such as
decreased mitochondrial aconitase activity (Cardoso et al.
2012). Taking this evidence into account, it is tempting to
suggest that the increase in oxidative stress and free fatty acids
levels associated to hypoglycemia contribute for the higher
sensitivity of mitochondria to UCPs-mediated proton-leak.
Our results also suggest that under both metabolic insults,
ANT is involved in proton-leak modulation whereas UCPs-
induced uncoupling prevails in recurrent hypoglycemia. Still,
more studies are needed to clarify the role of neuronal UCPs
(UCP2, UCP4, and UCP5) and ANT in hypoglycemia and/or
hyperglycemia. Understanding the mechanisms underlying the
distinct behavior of mitochondria under different metabolic
insults may allow the design of more effective therapeutic
strategies.
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